SCHEMBL5355787

SCHEMBL5355787

O=P(On1cccn1)(On1cccn1)On1cccn1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3970016 0.87 FDPS (0.31) FDPS
SCHEMBL668855 0.82 FDPS (0.40) FDPS
SCHEMBL2784162 0.76 KDM4E (0.36) FDPS
SCHEMBL2865767 0.71
SCHEMBL725601 0.68
SCHEMBL2840373 0.67
SCHEMBL876216 0.67
SCHEMBL11038490 0.67
SCHEMBL4106343 0.67 NOS1 (0.32)
SCHEMBL6386528 0.67 POLB (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7291692-B2 Polyarylene oxide and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-11-06 US disclosed
US-7161000-B2 Method for producing phenol condensate SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-01-09 US disclosed
US-20050096452-A1 Polyarylene oxide and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-05-05 US disclosed
US-6841650-B2 Crystallizable poly (2,5-di-substituted-1,4-phenylene oxide) and a method of preparing the same NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2005-01-11 US disclosed
US-20040267057-A1 Method for producing phenol condensate SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-30 US disclosed
EP-1029882-B1 A crystallizable poly(2,5-di-substituted-1, 4-phenylene oxide) and a method of preparing the same NAT INST OF ADVANCED IND SCIEN (JP) 2004-05-12 EP disclosed
US-6541596-B1 Subjecting a 2,5-di- substituted phenol to oxidative polymerization in the presence of oxygen and a copper complex catalyst composed of tridentate ligand of which nitrogen atoms are coordiante to a copper atom SECRETARY OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY 2003-04-01 US disclosed
US-20020183475-A1 Crystallizable poly (2,5-di-substituted-1,4-phenylene oxide) and a method of preparing the same SECRETARY OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY 2002-12-05 US disclosed
US-6383636-B2 MOLDING MATERIALS; IMPACT STRENGTH, HEAT RESISTANCE, SOLVENT RESISTANCE DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY, MINISTRY OF ECONOMY, TRADE AND INDUSTRY (JP) 2002-05-07 US disclosed
US-20020007020-A1 (2,5-disubstituted-1,4-phenylene oxide) block or graft copolymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-01-17 US disclosed
EP-1029882-A2 A crystallizable poly(2,5-di-substituted-1, 4-phenylene oxide) and a method of preparing the same Secretary of Agency of Industrial Science and Technology (JP) 2000-08-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040267057-A1 Method for producing phenol condensate SOD1, MLX, XDH FDPS 2176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.